Multicenter comparison of azithromycin and amoxicillin/clavulanate in the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease

1994, Mortality patterns—United States, 1992, MMWR. Morb Mortal Wkly Rep, 43, 916 Higgins, 1984, Epidemiology of COPD: State of the art, Chest, 85, 3S Owens, 1992, Advances in the treatment of chronic obstructive pulmonary disease, Hosp Formul, 27, 1012 Feinleib, 1989, Trends in COPD morbidity and mortality in the United States, Am Rev Respir Dis, 140, S9, 10.1164/ajrccm/140.3_Pt_2.S9 Schmidt, 1989, Acute or chronic respiratory failure: Assessment and management of patients with COPD in the emergent setting, JAMA, 261, 3444, 10.1001/jama.1989.03420230098035 1987, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma, Am Rev Respir Dis, 136, 225, 10.1164/ajrccm/136.1.225 Rosen, 1992, Treatment of exacerbations of COPD, Am Fam Phys, 45, 693 Rodnick, 1988, The use of antibiotics in acute bronchitis and acute exacerbations of chronic bronchitis, West J Med, 149, 347 Saint, 1995, Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis, JAMA, 273, 957, 10.1001/jama.1995.03520360071042 Perlman, 1990, Respiratory infections in ambulatory adults: Choosing the best treatment, Postgrad Med, 87, 175, 10.1080/00325481.1990.11704532 Schentag, 1991, Tissue-directed pharmacokinetics, Am J Med, 91, 5S, 10.1016/0002-9343(91)90394-D Hardy, 1988, Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides, Antimicrob Agents Chemother, 32, 1710, 10.1128/AAC.32.11.1710 Retsema, 1987, Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms, Antimicrob Agents Chemother, 31, 1939, 10.1128/AAC.31.12.1939 Olsen, 1995, Estimation of azithromycin concentrations in pulmonary tissues and serum after multiple oral doses in normal volunteers, Presented at the 1995 ATS International Conference Dark, 1993, Azithromycin versus cefaclor in the treatment of acute exacerbations of chronic obstructive pulmonary disease, Curr Ther Res, 53, 203, 10.1016/S0011-393X(05)80247-4 Wallace, 1988, Newer oral antimicrobials and newer etiologic agents of acute bronchitis and acute exacerbations of chronic bronchitis, Semin Respir Infect, 3, 49 Anthonisen, 1987, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease, Ann Intern Med, 106, 196, 10.7326/0003-4819-106-2-196 Chodosh, 1987, Acute bacterial exacerbations in bronchitis and asthma, Am J Med, 82, 154 Gross, 1990, Chronic obstructive pulmonary disease: Current concepts and therapeutic approaches, Chest, 97, 19S Chodosh, 1983, A comparison of doxycycline and cefaclor in acute bacterial exacerbations of chronic bronchial disease, Intern Med Specialist, 24 Wallace, 1985, Amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections caused by β-lactamase—positive Haemophilus influenzae and Branhamella catarrhalis, Antimicrob Agents Chemother, 27, 912, 10.1128/AAC.27.6.912 Hopkins, 1994, Clinical toleration and safety of azithromycin in adults and children, Rev Contemp Pharmacother, 5, 383 Honig, 1994, Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin and azithromycin on terfenadine steady-state pharmacokinetics and electrocardiographic parameters, Drug Invest, 7, 148, 10.1007/BF03258467 Periti, 1992, Pharmacokinetic drug interactions of macrolides, Clin Pharmacokinet, 23, 106, 10.2165/00003088-199223020-00004 Gardner, 1992, Lack of effect of azithromycin (AZ) on the pharmacokinetics (PK) of theophylline (T) in man, Presented at the Mediterranean Congress of Chemotherapy Eisen, 1990, The effect of prescribed daily dose frequency on patient medication compliance, Arch Intern Med, 150, 1881, 10.1001/archinte.1990.00390200073014 Bergman, 1963, Failure of children to receive penicillin by mouth, NEJM, 268, 1334, 10.1056/NEJM196306132682404 Nightingale, 1994, Cost issues and considerations when choosing antimicrobial agents, Infect Dis Clin Pract, 3, 8, 10.1097/00019048-199401000-00002